Natalie M. Meléndez-Vázquez

Dr. Natalie M. Meléndez-Vázquez

University of Puerto Rico-Medical Sciences Campus, San Juan, Puerto Rico, Puerto Rico
orcid
Postdoctoral fellow | Dept. of Microbiology and Medical Zool...

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
CGCandelaria Gomez-Manzano
Candelaria Gomez-Manzano
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Glioblastoma (GBM) is the most prevalent malignant brain tumor. Current standard-of-care treatments offer limited benefits for patient survival. Virotherapy is emerging as a novel strategy to use oncolytic viruses (OVs) for the treatment of GBM. These engineered and non-engineered viruses infect and lyse cancer cells, causing tumor destruction without harming healthy cells. Recent advances in genetic modifications to OVs have helped improve their targeting capabilities and introduce therapeutic genes, broadening the therapeutic window and minimizing potential side effects. The efficacy of oncolytic virotherapy can be enhanced by combining it with other treatments such as immunotherapy, chemotherapy, or radiation. Recent studies suggest that manipulating the gut microbiome to enhance immune responses helps improve the therapeutic efficacy of the OVs. This narrative review intends to explore OVs and their role against solid tumors, especially GBM while emphasizing the latest technologies used to enhance and improve its therapeutic and clinical responses.

30 May 2024 in Cancers
Verified
Journal Article
Open access
PDF file
JDJennifer Díaz-Rivera
Jennifer Díaz-Rivera
MRMichael Anthony Rodríguez-Rivera
Michael Anthony Rodríguez-Rivera
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Stephanie Dorta-EstremeraStephanie Dorta-Estremera
Stephanie Dorta-Estremera
The United States is suffering from an epidemic associated with high-risk strains of the Human Papillomavirus (HPV) predominantly responsible for the development of head and neck squamous cell carcinoma (HNSCC). Treatment with immune checkpoint inhibitors targeting programmed death 1 (PD-1) or its ligand PD-L1 has shown poor efficacy in HNSCC patients, observing only a 20–30% response. Therefore, biological marker identification associated with PD-1 blockade response is important to improve prognosis and define novel therapeutics for HNSCC patients. Therapy response was associated with increased frequencies of activated CD27+T cells, activated CD79a+ B cells, antigen-presenting CD74+ dendritic and B cells, and PD-L1+ and PD-L2+ myeloid-derived suppressor cells (MDSCs). The oral microbiota composition differed significantly in mice bearing tongue tumors and treated with anti-PD-1. A higher abundance of Allobaculum, Blautia, Faecalibacterium, Dorea, or Roseburia was associated with response to the therapy. However, an increase in Enterococcus was attributed to tongue tumor-bearing non-responding mice. Our findings indicate that differences in immune phenotypes, protein expression, and bacterial abundance occur as mice develop tongue tumors and are treated with anti-PD-1. These results may have a clinical impact as specific bacteria and immune phenotype could serve as biomarkers for treatment response in HNSCC.

7 October 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Luis Horacio Pagan RiveraLuis Horacio Pagan Rivera
Luis Horacio Pagan Rivera
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
SOSamuel Ocasio
Samuel Ocasio
MSMaría E. Santiago-Gascot
María E. Santiago-Gascot
JMJorge David Miranda
Jorge David Miranda
Spinal cord injury (SCI) is a devastating neurological state that could lead to motor, sensory, and autonomic dysfunction. In addition to its direct impact on the central nervous system, SCI exerts systemic effects, including disruption of gut homeostasis and alterations in the gut microbiota, which can contribute to sustained inflammation and hinder functional recovery. While antibiotic administration during the acute phase of SCI is clinically indicated, it may exacerbate microbial dysbiosis. In this study, we investigate the combined effects of SCI and cefazolin treatment on the gut microbiome of female rats. Animals were assigned to three groups: NAÏVE (no intervention), SHAM (cefazolin only), and INJURY (T10 spinal cord contusion plus cefazolin). Cefazolin was administered for seven days after the injury, fecal samples were collected at baseline (day 0), and on days 7, 14, 21, and 28 post-SCI. DNA was extracted and subjected to 16S rRNA gene amplicon sequencing, followed by bioinformatic analysis. Our findings revealed significant microbial dysbiosis in the INJURY group, including reduced alpha diversity and distinct shifts in microbial composition. These changes were most prominent during the acute phase post-SCI. Our findings highlight the compounding effects of spinal trauma and antibiotic exposure on the gut microbiome and suggest that maintaining microbial stability may represent a promising avenue to support recovery after SCI.

21 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Luis Horacio Pagan RiveraLuis Horacio Pagan Rivera
Luis Horacio Pagan Rivera
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
SOSamuel Ocasio
Samuel Ocasio
MSMaría E. Santiago-Gascot
María E. Santiago-Gascot
JMJorge David Miranda
Jorge David Miranda
Spinal cord injury (SCI) is a devastating neurological state that could lead to motor, sensory, and autonomic dysfunction. In addition to its direct impact on the central nervous system, SCI exerts systemic effects, including disruption of gut homeostasis and alterations in the gut microbiota, which can contribute to sustained inflammation and hinder functional recovery. While antibiotic administration during the acute phase of SCI is clinically indicated, it may exacerbate microbial dysbiosis. In this study, we investigate the combined effects of SCI and cefazolin treatment on the gut microbiome of female rats. Animals were assigned to three groups: NAÏVE (no intervention), SHAM (cefazolin only), and INJURY (T10 spinal cord contusion plus cefazolin). Cefazolin was administered for seven days after the injury, fecal samples were collected at baseline (day 0), and on days 7, 14, 21, and 28 post-SCI. DNA was extracted and subjected to 16S rRNA gene amplicon sequencing, followed by bioinformatic analysis. Our findings revealed significant microbial dysbiosis in the INJURY group, including reduced alpha diversity and distinct shifts in microbial composition. These changes were most prominent during the acute phase post-SCI. Our findings highlight the compounding effects of spinal trauma and antibiotic exposure on the gut microbiome and underscore the importance of microbial stability in SCI recovery.

13 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
NCNataliya Chorna
Nataliya Chorna
CNCecilia Noecker
Cecilia Noecker
ACAndrea P. Cortes-Nazario
Andrea P. Cortes-Nazario
JRJosefina Romaguera
Josefina Romaguera
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Background: Cervical cancer is primarily caused by the human papillomavirus (HPV), with persistent infections progressing to low- (LGSIL) and high-grade (HGSIL) lesions. Emerging evidence indicates that the cervicovaginal microbiota influences HPV persistence and disease progression, although the underlying metabolic mechanisms remain unclear. Therefore, we assessed the relationship between the cervicovaginal microbiota and the metabolic milieu in women with cervical dysplasia and HPV infections. Methods: We recruited 36 non-menopausal, non-pregnant women who were classified as negative, LGSIL, or HGSIL based on pathology and HPV results. Cervical swabs were collected for genomic DNA extraction to characterize bacterial communities using 16S rRNA sequencing and to perform HPV genotyping. Cervical lavages were collected for untargeted metabolomic profiling using Gas Chromatography-Mass Spectrometry. Integrative multiomic analysis was performed using the MIMOSA2 pipeline. Results: Although bacterial community structure was not different between groups, women with HGSIL had higher richness and exhibited a higher abundance of Prevotella bivia, Prevotella buccalis, and Lachnospiraceae G-9 oral taxon 924. Lesion-positive samples had shifts in tyramine and putrescine, biogenic amines linked to cancer development. Specifically, Pseudomonas was identified as a potential contributor to tyramine oxidation. Conclusions: Cervical lesions and HPV risk are associated with shifts in the cervicovaginal microbial metabolic milieu, highlighting the role of low-abundant anaerobic bacteria. Despite the small sample size, biogenic amines were associated with anaerobic taxa and microbial dysbiosis. These findings warrant further assessment of microbial-derived metabolites and their potential to promote tumor progression by driving a pro-inflammatory, metabolically altered microenvironment.

Verified
Journal Article
Open access
PDF file
María Del Mar Figueroa GispertMaría Del Mar Figueroa Gispert
María Del Mar Figueroa Gispert
Natalie M. Meléndez-VázquezNatalie M. Meléndez-Vázquez
Natalie M. Meléndez-Vázquez
AEAna M Espino
Ana M Espino
FGFilipa Godoy-Vitorino
Filipa Godoy-Vitorino
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by dysbiosis of the gut microbiota. Helminth infections are known to modulate host immunity and intestinal microbial composition; however, the therapeutic use of live parasites poses safety challenges. The recombinant Fasciola hepatica fatty acid-binding protein Fh15 is a helminth-derived molecule with anti-inflammatory effects in models of septic shock and dextran sulfate sodium (DSS)-induced colitis. Whether Fh15 also influences gut microbial composition during colitis remains unknown. Male C57BL/6 mice received 4% DSS in drinking water for 7 days to induce colitis and were treated intraperitoneally with Fh15 (2 mg/kg) on days 1, 3, and 5. Fecal samples were collected on days 2, 4, and 7 for 16S rRNA gene sequencing. Standard microbiota pipelines were used to evaluate community diversity. Acute DSS treatment disrupted gut microbial diversity and community structure compared with non-colitic controls. Fh15 treatment partially restored early microbial balance by shifting microbial composition toward that of healthy mice and reducing microbial dispersion, indicating enhanced community stability despite severe dysbiosis. Although alpha diversity did not return to control levels, Fh15 mitigated the expansion of pro-inflammatory genera (Enterococcus and Turicibacter) and preserved beneficial taxa, including Adlercreutzia.